Emodin inhibits NF-κB signaling pathway to protect obese asthmatic rats from pathological damage via Visfatin
Authors:
- 13 December 2021
- journal article
- research article
- Published by Elsevier in Tissue and Cell
- Vol. 74, 101713
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Interleukin‐33 exacerbates allergic bronchoconstriction in the mice via activation of mast cellsAllergy, 2015
- Adipocytokines in obesity and metabolic diseaseJournal of Endocrinology, 2014
- Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancerCancer Letters, 2013
- Visfatin/NAMPT: A Multifaceted Molecule with Diverse Roles in Physiology and PathophysiologyAnnual Review of Nutrition, 2012
- Emodin Protects against High-Fat Diet-Induced Obesity via Regulation of AMP-Activated Protein Kinase Pathways in White Adipose TissuePlanta Medica, 2012
- Emodin, a naturally occurring anthraquinone derivative, suppresses IgE-mediated anaphylactic reaction and mast cell activationBiochemical Pharmacology, 2011
- Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunityJournal of Leukocyte Biology, 2008
- Overweight, Obesity, and Incident AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Uncontrolled asthma: A review of the prevalence, disease burden and options for treatmentRespiratory Medicine, 2006
- Relationship of indoor allergen exposure to skin test sensitivity in inner-city children with asthmaJournal of Allergy and Clinical Immunology, 1998